CA2257662A1 - Quinoline derivatives as tachykinin nk3 receptor antagonists - Google Patents

Quinoline derivatives as tachykinin nk3 receptor antagonists

Info

Publication number
CA2257662A1
CA2257662A1 CA002257662A CA2257662A CA2257662A1 CA 2257662 A1 CA2257662 A1 CA 2257662A1 CA 002257662 A CA002257662 A CA 002257662A CA 2257662 A CA2257662 A CA 2257662A CA 2257662 A1 CA2257662 A1 CA 2257662A1
Authority
CA
Canada
Prior art keywords
receptor antagonists
tachykinin
quinoline derivatives
disorders
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002257662A
Other languages
French (fr)
Other versions
CA2257662C (en
Inventor
Carlo Farina
Giuseppe Arnaldo Maria Giardina
Mario Grugni
Luca Francesco Raveglia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT94MI001099A external-priority patent/ITMI941099A1/en
Priority claimed from ITMI950494 external-priority patent/IT1293558B1/en
Application filed by Individual filed Critical Individual
Priority claimed from CA002191352A external-priority patent/CA2191352C/en
Publication of CA2257662A1 publication Critical patent/CA2257662A1/en
Application granted granted Critical
Publication of CA2257662C publication Critical patent/CA2257662C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NK3 receptor antagonists of formula (I) are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
CA002257662A 1994-05-27 1995-05-23 Quinoline derivatives as tachykinin nk3 receptor antagonists Expired - Fee Related CA2257662C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IT94MI001099A ITMI941099A1 (en) 1994-05-27 1994-05-27 KINOLINIC DERIVATIVES
ITMI94A001099 1994-05-27
ITMI95A000494 1995-03-14
ITMI950494 IT1293558B1 (en) 1995-03-14 1995-03-14 New tachykinin receptor antagonising quinoline derivs. - used for treating pulmonary disorders, CNS disorders, skin disorders, neurogenic inflammation, epilepsy and inflammatory pain,etc.
CA002191352A CA2191352C (en) 1994-05-27 1995-05-23 Quinoline derivatives as tachykinin nk3 receptor antagonists

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002191352A Division CA2191352C (en) 1994-05-27 1995-05-23 Quinoline derivatives as tachykinin nk3 receptor antagonists

Publications (2)

Publication Number Publication Date
CA2257662A1 true CA2257662A1 (en) 1995-12-07
CA2257662C CA2257662C (en) 2005-03-29

Family

ID=27170234

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002257662A Expired - Fee Related CA2257662C (en) 1994-05-27 1995-05-23 Quinoline derivatives as tachykinin nk3 receptor antagonists

Country Status (1)

Country Link
CA (1) CA2257662C (en)

Also Published As

Publication number Publication date
CA2257662C (en) 2005-03-29

Similar Documents

Publication Publication Date Title
CA2191352A1 (en) Quinoline Derivatives as Tachykinin NK3 Receptor Antagonists
CA2183250A1 (en) Prodrugs of morpholine tachykinin receptor antagonists
CY2505B1 (en) Quinoline derivatives as nk3 antagonists
WO2000035919A3 (en) Quinoline derivatives
CA2198238A1 (en) Piperidine derivatives as neurokinin antagonists
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
CA2109415A1 (en) Substituted 3-Aminoquinuclidines
PL326928A1 (en) Quinolin-4-carboxyamidic derivatives, their production and their application as antagonists ofneurokinin-3 (nk-3) and neurokinin-2 (nk-2)
CA2297911A1 (en) Substituted 6-phenylphenanthridines
CA2250569A1 (en) Novel phenanthridines substituted in the 6 position
IE902288L (en) Tetrazolylmethylpiperidine carboxylic acid
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
AU3567195A (en) Neurokinin antagonists
CA2064373A1 (en) Piperidine derivatives
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
CA2257662A1 (en) Quinoline derivatives as tachykinin nk3 receptor antagonists
GB9323162D0 (en) 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
CA2157234A1 (en) Stereoselective process for producing dihydro-2-3-benzodiazepine derivatives
AU1574995A (en) Tachykinins antagonists
GB9705861D0 (en) Trypthophan ureas as neurokinin antagonists
NO985535L (en) Process for the preparation of 1,3-alkanediols
DE69800092T2 (en) Substituted 4- (6-fluoro- [1H] -indol-3-yl) 1,2,3,6-tetrahydropyridine derivatives for the treatment of CNS disorders
IE840831L (en) 1,4-dihydropyridine derivatives
CA2275527A1 (en) Novel heterocyclic substituted pyrrolidine amide derivatives
PL328514A1 (en) 1,4-dihydropyridine compounds as antagonists of bradykinin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed